2019 annual financial data
Ovid Therapeutics 2019 Operating margin
Ovid Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -61,409,467 USD and net income was -59,258,017 USD.
Operating cash flow was -51,090,622 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -61,409,467 USD
- Net income
- -59,258,017 USD
- Operating cash flow
- -51,090,622 USD